Latest News

01.27.21

Verana Health Announces Real-World Data and Data Science Collaboration Agreement with Janssen

Source: Verana Health

01.27.21

Surface Ophthalmics Announces First Patient Dosed in Head-to-Head Phase 2 Trial for SURF-100 for Chronic Dry Eye Disease

Source: Surface Ophthalmics

01.27.21

US to Bolster COVID-19 Vaccine Supply With Millions More Doses this Summer

Source: FirstWord

01.27.21

Regeneron’s Antibody Cocktail Shows Promise as ‘Passive Vaccine’ Against COVID-19

Source: FirstWord

01.27.21

Neurophth Therapeutics Appoints Qiutang Li, PhD, as Chief Scientific Officer

Source: Neurophth Therapeutics

01.27.21

Google Commits $150M to COVID-19 Vaccine Education, Partnering With One Medical to Open Vaccination Sites

Source: FierceHealthcare

01.26.21

DORC Announces Health Canada Approval of Tissueblue for Staining of the ILM During Vitreoretinal Surgery

Source: DORC

01.26.21

Elizabeth Yeu, MD, and K. Peony Yu, MD, Appointed to Staar Surgical Board of Directors

Source: Staar Surgical

01.26.21

Bariatric Surgery May Curb Diabetic Eye Disease Incidence but Worsen Existing Retinopathy

Source: Reuters

01.26.21

Zenni Releases New Anti-Fog Glasses Lenses to Address Mask-Related Fogging

Source: Zenni

01.26.21

Leo Lens Pharma Announces Corporate Name Change to MediPrint Ophthalmics

Source: MediPrint Ophthalmics

01.25.21

Merck Shuts Down Covid Vaccine Program After Lackluster Data

Source: Bloomberg

01.25.21

Genentech’s Faricimab Meets Primary Endpoint in Two Global Phase 3 Studies in Wet AMD

Source: Genentech

01.25.21

Ace Vision Group Closes Series A Stock Round to Advance Ophthalmic Technologies

Source: Ace Vision Group

01.22.21

Eyedaptic Augmented Reality Visual Aid Granted Patent to Further Aid Those With Macular Degeneration and Low Vision

Source: Eyedaptic

01.22.21

FTC to Probe Physician Practice Consolidation and Impact on Market Competition

Source: FierceHealthcare

View more stories